Section Arrow
Quote
CPRX.NASDAQ
- Catalyst Pharmaceuticals
Quotes are at least 15-min delayed:2024/05/16 15:00 EDT
Last
 16.43
-0.23 (-1.38%)
Day High 
16.82 
Prev. Close
16.66 
1-M High
17.03 
Volume 
688.23K 
Bid
16.42
Ask
16.43
Day Low
16.36 
Open
16.6 
1-M Low
14.47 
Market Cap 
1.97B 
Currency USD 
P/E 29.75 
%Yield 0 
10-SMA 15.56 
20-SMA 15.3 
50-SMA 15.67 
52-W High 17.495 
52-W Low 11.09 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.56/1.67
Enterprise Value
1.97B
Balance Sheet
Book Value Per Share
4.75
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
398.20M
Operating Revenue Per Share
2.95
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.10275+0.02505+32.24%-- 
NBYNovaBay Pharmaceuticals0.121+0.0165+15.79%-- 
JAGXJaguar Health0.290812+0.035712+14.00%-- 
DNAGinkgo Bioworks Holdings0.82755-0.01155-1.38%-- 
NVAXNovavax14.6007+1.7007+13.18%-- 
Quotes are at least 15-min delayed：2024/05/16 15:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.